Radiotherapy Combined With Thymosin for Metastatic NSCLC Patients Who Showed Stable Disease After First Line TKI Therapy
Clinical trial NCT02787447 · UNKNOWN
Trial details
- NCT number
- NCT02787447
- Sponsor
- First People's Hospital of Hangzhou
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-01
- Primary completion
- 2017-12-01
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.